Fosun Pharma announced that its wholly-owned subsidiary Fosun Pharma Singapore Co., Ltd. sold 9,900,000 shares of Gland Pharma (accounting for 6.01% of the total shares of Gland Pharma as of June 19, 2024) at an average price of INR 1,771.81 per share (pre-tax), with a total transaction price of INR 17.541 billion (pre-tax), equivalent to approximately USD 211 million (pre-tax) through block trades.
复星医药：出售控股子公司Gland Pharma Limited 6.01%股权
Fosun Pharma: Sells 6.01% equity stake in Gland Pharma Limited, its holding subsidiary.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.